MUMBAI (Reuters) - Shares in Sun Pharmaceutical Industries Ltd slumped as much as 10.9 percent on Tuesday, heading towards their biggest daily fall since June 2009 after Japan's Daiichi Sankyo Co Ltd started selling its stake in the Indian drugmaker.
Daiichi Sankyo kickstarted the sale of the Sun Pharma stake, worth up to $3.6 billion, on Monday, according to a person directly involved in the deal and a marketing term sheet seen by Reuters, through accelerated book building.
The stake sale will have a negative impact on the stock as it was done at price lower than market level, and it could imply that Daiichi feels that the remediation measures will take more time, said Sapna Jhawar analyst at Reliance Securities.
"This also indicates that Ranbaxy's integration will be little challenging for Sun Pharma," she added.
Shares in Sun Pharma were down 8.8 percent to 952.10 rupees at 12:05 p.m.
(Reporting by ABhishek Vishnoi; Editing by Anand Basu)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app